1. Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model;Rosenthal;PLoS Med,2007
2. St. George’s Hospital Medical School, An international multicentre controlled clinical trial to evaluate high dose RIFApentine and a QUINolone in the treatment of pulmonary tuberculosis high dose RIFApentine high dose RIFApentine and a QUINolone in the treatment of pulmonary tuberculosis (RIFAQUIN), ISRCTN44153044, http://apps.who.int/trialsearch/default.aspx.
3. APRIORI, Pharmacokinetics and pharmacodynamics of high versus standard dose rifampicin in patients with pulmonary tuberculosis (High RIF), clinicaltrials.gov identifier NCT00760149.
4. Johns Hopkins University, Study of daily rifapentine for pulmonary tuberculosis, clinicaltrials.gov identifier NCT00814671.
5. U.S. Centers for Disease Control and Prevention, TBTC Study 29: rifapentine during intensive phase tuberculosis (TB) treatment, clinicaltrials.gov identifier NCT00694629.